• Home
  • About
    • Team Members
  • Services
    • Research & Development
    • Manufacturing
      • Liquid Dose Manufacturing
      • Solid Dose Manufacturing
      • Gummy Manufacturing
    • Packaging
    • Quality Assurance
  • Facilities
  • News
    • White Paper: The Promise of Gummies as a Drug Delivery System
    • White Paper: Flavor Masking for Rx and OTC Drugs
    • Join Avéma Pharma Solutions at CPhI North America
  • Contact
  • Resources
    • PLD Pharma Services at a Glance
    • PLD Pharma Services Overview
    • Your ANDA or Ours?
    • Strategies & Solutions for Launching OTC and Rx Gummies
    • The Promise of Gummies as a Delivery System
    • Flavor Masking White Paper
    • RFQ Checklist
  • PLD Product Catalog
  • PLD ANDA List 2026
PLD Pharma Services
Menu
  • Home
  • About
    • Team Members
  • Services
    • Research & Development
    • Manufacturing
      • Liquid Dose Manufacturing
      • Solid Dose Manufacturing
      • Gummy Manufacturing
    • Packaging
    • Quality Assurance
  • Facilities
  • News
    • White Paper: The Promise of Gummies as a Drug Delivery System
    • White Paper: Flavor Masking for Rx and OTC Drugs
    • Join Avéma Pharma Solutions at CPhI North America
  • Contact
  • Resources
    • PLD Pharma Services at a Glance
    • PLD Pharma Services Overview
    • Your ANDA or Ours?
    • Strategies & Solutions for Launching OTC and Rx Gummies
    • The Promise of Gummies as a Delivery System
    • Flavor Masking White Paper
    • RFQ Checklist
  • PLD Product Catalog
  • PLD ANDA List 2026
Contract Pharma
Pharmaceutical Manufacturing

Choosing the Right Path to Commercialization

November 6, 2026 / 107
Contract Pharma

Bringing a pharmaceutical product to market doesn’t always mean starting from scratch. Leveraging an existing ANDA, optimizing a legacy manufacturing process, or transferring an approved product may offer a faster, more cost-effective path to commercialization. Read the article here.

Innovative Ways to Expand Your Brand Portfolio and Bring New Products to Market

Bringing a pharmaceutical product to market doesn’t always mean starting from scratch. Leveraging an existing ANDA, optimizing a legacy manufacturing process, or transferring an approved product may offer a faster, more cost-effective path to commercialization.

In this Contract Pharma article, Aaron Dely, Vice President of Research & Development at PLD Pharma Services, explores four commercialization strategies and the technical, regulatory, and financial considerations that influence each decision. Through real-world examples, he demonstrates how the right combination of formulation expertise, regulatory knowledge, and manufacturing capabilities can help pharmaceutical companies accelerate product launches while reducing development costs and risk.

Discover how choosing the right commercialization pathway can give your next product a competitive advantage.

Share Post
Previous
Join PLD Pharma Services at DCAT Week 2026

About Author

Avema

Other posts by Avema

Comments are closed

HomeAbout UsServicesFacilitiesContact UsFaqs
© 2025. All Rights Reserved
Contact: 1.516.693.7384